Remodeling in the ischemic heart: The stepwise progression for heart failure

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 9, 2011, Pages 890-898

  Mill, J G ^a   Stefanon, I ^a   dos Santos, L ^a   Baldo, M P ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Collagen remodeling; Coronary occlusion; Heart failure; Inflammation; Mechanical dysfunction; Rats

Indexed keywords

COLLAGEN;

ACUTE HEART INFARCTION; APOPTOSIS; CELL DEATH; DISEASE COURSE; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; NONHUMAN; REVIEW;

ANIMALIA; RATTUS;

EID: 80053318827     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500096     Document Type: Review

References (60)

1. dos Santos L, Santos AA, Goncalves GA, Krieger JE, Tucci PJ. Bone marrow cell therapy prevents infarct expansion and improves border zone remodeling after coronary occlusion in rats. Int J Cardiol 2010; 145: 34-39.
2. Simonis G, Wiedemann S, Schwarz K, Christ T, Sedding DG, Yu X, et al. Chelerythrine treatment influences the balance of pro-and anti-apoptotic signaling pathways in the remote myocardium after infarction. Mol Cell Biochem 2008; 310: 119-128.
3. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001; 280: H2726-H2731.
4. Jiang L, Huang Y, Hunyor S, dos Remedios CG. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 2003; 24: 742-751.
5. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503-512.
6. Pereira RB, Sartorio CL, Vassallo DV, Stefanon I. Differences in tail vascular bed reactivity in rats with and without heart failure following myocardial infarction. J Pharmacol Exp Ther 2005; 312: 1321-1325.
7. Sartorio CL, Fraccarollo D, Galuppo P, Leutke M, Ertl G, Stefanon I, et al. Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension 2007; 50: 919-925.
8. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
9. Jourdan-Lesaux C, Zhang J, Lindsey ML. Extracellular matrix roles during cardiac repair. Life Sci 2010; 87: 391-400.
10. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003; 108: 2905-2910.
11. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2008; 102: 257-264.
12. Deten A, Volz HC, Briest W, Zimmer HG. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002; 55: 329-340.
13. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007; 87: 1285-1342.
14. Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarct expansion. Circulation 1991; 84: 2123-2134.
15. Dean RG, Balding LC, Candido R, Burns WC, Cao Z, Twigg SM, et al. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 2005; 53: 1245-1256.
16. Milanez MC, Gomes MG, Vassallo DV, Mill JG. Effects of captopril on interstitial collagen in the myocardium after infarction in rats. J Card Fail 1997; 3: 189-197.
17. Mill JG, Milanez MC, de Resende MM, Gomes MG, Leite CM. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 2003; 30: 739-744.
18. Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, et al. Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 2003; 284: H122-H132.
19. Mill JG, Vassallo DV, Leite CM. Time course of changes in heart rate and sympathetic tone after coronary artery ligation in rats. Braz J Med Biol Res 1991; 24: 855-858.
20. Modolo RP, Bernardes CF, Vasquez EC, Mill JG. [Evaluation of the vagal efferent pathway in rats in the acute and chronic phases of myocardial infarction]. Arq Bras Cardiol 1995; 65: 17-22.
21. Meyrelles SS, Mill JG, Cabral AM, Vasquez EC. Cardiac baroreflex properties in myocardial infarcted rats. J Auton Nerv Syst 1996; 60: 163-168.
22. Meyrelles SS, Bernardes CF, Modolo RP, Mill JG, Vasquez EC. Bezold-Jarisch reflex in myocardial infarcted rats. J Auton Nerv Syst 1997; 63: 144-152.
23. Westcott KV, Huang BS, Leenen FH. Brain renin-angiotensin-aldosterone system and ventricular remodeling after myocardial infarct: a review. Can J Physiol Pharmacol 2009; 87: 979-988.
24. Huang BS, Ahmad M, Tan J, Leenen FH. Chronic central versus systemic blockade of AT(1) receptors and cardiac dysfunction in rats post-myocardial infarction. Am J Physiol Heart Circ Physiol 2009; 297: H968-H975.
25. Araujo IG, Trindade DC, Mecawi AS, Sonoda-Cortes R, Werneck-de-Castro JP, Costa-E-Sousa RH, et al. Inhibition of brain renin-angiotensin system improves diastolic cardiac function following myocardial infarction in rats. Clin Exp Pharmacol Physiol 2009; 36: 803-809.
26. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of longterm therapy with captopril. Circulation 1985; 72: 406-412.
27. Busatto VC, Cicilini MA, Mill JG. Increased angiotensinconverting enzyme activity in the left ventricle after infarction. Braz J Med Biol Res 1997; 30: 679-687.
28. Resende MM, Mill JG. Alternate angiotensin II-forming pathways and their importance in physiological or physiopathological conditions. Arq Bras Cardiol 2002; 78: 425-438.
29. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996; 28: 851-858.
30. de Resende MM, Kauser K, Mill JG. Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats. Life Sci 2006; 78: 3066-3073.
31. Mill JG, Gomes AP, Carrara AB, Gomes MG, Vassallo DV. Influence of chronic captopril therapy on the mechanical performance of the infarcted rat heart. Pharmacol Res 1994; 29: 77-88.
32. Paul M, Poyan MA, Kreutz R. Physiology of local reninangiotensin systems. Physiol Rev 2006; 86: 747-803.
33. Xu J, Carretero OA, Lin CX, Cavasin MA, Shesely EG, Yang JJ, et al. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am J Physiol Heart Circ Physiol 2007; 293: H1900-H1907.
34. Adachi Y, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003; 107: 2406-2408.
35. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the reninangiotensin system in myocardial infarction? Circulation 2008; 118: 2523-2532.
36. Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, et al. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 2008; 51: 905-914.
37. Nabah YN, Mateo T, Estelles R, Mata M, Zagorski J, Sarau H, et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 2004; 110: 3581-3586.
38. dos Santos L, Antonio EL, Souza AF, Tucci PJ. Use of afterload hemodynamic stress as a practical method for assessing cardiac performance in rats with heart failure. Can J Physiol Pharmacol 2010; 88: 724-732.
39. Fedak PW, Verma S, Weisel RD, Li RK. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol 2005; 14: 1-11.
40. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 2006; 48: 326-341.
41. Clerk A, Sugden PH. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol 1999; 83: 64H-69H.
42. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 2004; 322: 1178-1191.
43. Mill JG, Stefanon I, Leite CM, Vassallo DV. Changes in performance of the surviving myocardium after left ventricular infarction in rats. Cardiovasc Res 1990; 24: 748-753.
44. Stefanon I, Auxiliadora-Martins M, Vassallo DV, Mill JG. Analysis of right and left ventricular performance of the rat heart with chronic myocardial infarction. Braz J Med Biol Res 1994; 27: 2667-2679.
45. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology 2006; 21: 380-387.
46. Novaes MA, Stefanon I, Mill JG, Vassallo DV. Contractility changes of the right and ventricular muscle after chronic myocardial infarction. Braz J Med Biol Res 1996; 29: 1683-1690.
47. 2+ handling. Circ Res 2001; 89: 831-837.
48. Sallinen P, Manttari S, Leskinen H, Ilves M, Ruskoaho H, Saarela S. Time course of changes in the expression of DHPR, RyR(2), and SERCA2 after myocardial infarction in the rat left ventricle. Mol Cell Biochem 2007; 303: 97-103.
49. Palmer BM. Thick filament proteins and performance in human heart failure. Heart Fail Rev 2005; 10: 187-197.
50. 2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation 2008; 118: 614-624.
51. Sande JB, Sjaastad I, Hoen IB, Bokenes J, Tonnessen T, Holt E, et al. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res 2002; 53: 382-391.
52. Dixon IM, Hata T, Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol 1992; 262: H1387-H1394.
53. 2+ exchange during cardiac hypertrophy after myocardial infarction. Circ Res 2002; 91: 323-330.
54. Baldo MP, Davel AP, Nicoletti-Carvalho JE, Bordin S, Rossoni LV, Mill JG. Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats. J Cardiovasc Pharmacol 2008; 52: 375-380.
55. Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 1995; 92: 253-261.
56. Clements-Jewery H, Andrag E, Hearse DJ, Curtis MJ. Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats. Br J Pharmacol 2009; 156: 444-453.
57. Santos PE, Barcellos LC, Mill JG, Masuda MO. Ventricular action potential and L-type calcium channel in infarctinduced hypertrophy in rats. J Cardiovasc Electrophysiol 1995; 6: 1004-1014.
58. Antoons G, Sipido KR. Targeting calcium handling in arrhythmias. Europace 2008; 10: 1364-1369.
59. Yao JA, Jiang M, Fan JS, Zhou YY, Tseng GN. Heterogeneous changes in K currents in rat ventricles three days after myocardial infarction. Cardiovasc Res 1999; 44: 132-145.
60. + channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol 2000; 11: 1252-1261.